Helicon Group Limited

ASX:HCG ISIN:AU000000HCG1

2012年5月25日

概覽 | 新聞 | 多媒體 | 研究

Helicon Group Limited 公司資料

Helicon is listed on the Australian Securities Exchange. The Company's business is to identify and exploit niche market opportunities in the biomedical markets of North Asia, specifically China and to participate in the significant growth that has been projected for these markets over the next 25 years.

Helicon looks for "Special Situations" for advanced Western biopharmaceutical products that are not available in China or other North Asian Markets or where there are market needs that are not being adequately provided for.

Helicon's product partners are likely to be innovative small to medium sized pharmaceutical and healthcare enterprises focused largely on western markets.

Helicon seeks exclusive licenses for the designated markets and utilises a low cost operating overhead base in combination with established channel partners for product registration, distribution, marketing, and sales.

財務報告

公司詳細

	總部	Suite 3, 257 York Street

		SUBIACO WA 6008

		Australia

	電話	+61-8-9388-3683

	傳真	+61-8-9382-1766

	主要部門	醫療-製藥

	支柱產業	生物科技

	主頁	www.helicongroup.com.au

Key Developments: Helicon Group Limited

	2011年10月18日亞洲活動報告：Algae. Tec Limited (ASX:AEB)將在悉尼建海藻示範工廠，提供替代燃料解決方案 OCT 18, 2011 13:03 - Article Views: 783 2011年10月18日亞洲活動報告：Algae. Tec Limited (ASX:AEB)已收到監管部門批准，允許其在悉尼南部建立一座海藻示範工廠；Helicon Group Limited (ASX:HCG) 今天宣布執行收購Aspen Medisys的最終協議；Alkane Resources Limited (ASX:ALK)已與新南威爾士州政府簽訂一份協議，接受政府給予新南威爾士州中西部的Tomingley金礦項目基礎設施開發的財政援助；Transerv Energy Limited ( ASX:TSV)已完成對西澳Warro-4陸上井上層為期10天的首次測試；Augur Resources Limited (ASX:AUK)報告在爪哇中部Wonogiri項目的Randu Kuning探礦區取得的大量金銅結果。